Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bakkum

Showing results (171-180 of 347) with videos related to

Pageof 35
Sort By:
Neuroendocrinology|August 1, 1994
Central stimulation of renin secretion through serotonergic, noncardiovascular mechanismsP A Rittenhouse, E A Bakkum, A D Levy, et al.
Journal of Intellectual Disabilities : JOID|October 25, 2023
Pushing the boundaries of digital social contact: Experiences of people with disabilities and their social networks during the COVID-19 pandemicLianne Bakkum, Lotte Piekema, Linda Douma, et al.
Nederlands Tijdschrift Voor Geneeskunde|August 5, 2021
[Complications of contaminated drugs: how to reduce the number of future victims?]Philip G Frankenmolen, Caroline L Hoogerheide-Wiegerinck, Floor F van Bakkum, et al.
Gynecologic Oncology|November 9, 2007
Müllerian inhibiting substance type II receptor (MISIIR): a novel, tissue-specific target expressed by gynecologic cancersJamie N Bakkum-Gamez, Giovanni Aletti, Kriste A Lewis, et al.
Gynecologic Oncology|June 5, 2017
Cost-effectiveness of opportunistic salpingectomy for ovarian cancer preventionSarah E Dilley, Laura J Havrilesky, Jamie Bakkum-Gamez, et al.
Gynecologic Oncology|November 10, 2021
The cost of diagnosing endometrial cancer: Quantifying the healthcare cost of an abnormal uterine bleeding workupSimrit K Warring, Bijan Borah, James Moriarty, et al.
American Journal of Obstetrics and Gynecology|September 25, 2001
The severity of immune fetal hydrops is predictive of fetal outcome after intrauterine treatmentI L van Kamp, F J Klumper, R S Bakkum, et al.
Gynecologic Oncology|January 18, 2014
Oncolytic vaccinia virotherapy for endometrial cancerYu-Ping Liu, Jiahu Wang, Victoria A Avanzato, et al.
Gynecologic Oncology|November 20, 2013
Oncolytic measles and vesicular stomatitis virotherapy for endometrial cancerYu-Ping Liu, Michael B Steele, Lukkana Suksanpaisan, et al.
Gynecologic Oncology|December 4, 2018
Mesenchymal molecular subtype is an independent predictor of severe postoperative complications after primary debulking surgery for advanced ovarian cancerDiogo Torres, Amanika Kumar, Jamie N Bakkum-Gamez, et al.
Pageof 35

Showing results (171-180 of 347) with videos related to

Sort By:
Pageof 35
Neuroendocrinology|August 1, 1994
Central stimulation of renin secretion through serotonergic, noncardiovascular mechanismsP A Rittenhouse, E A Bakkum, A D Levy, et al.
Journal of Intellectual Disabilities : JOID|October 25, 2023
Pushing the boundaries of digital social contact: Experiences of people with disabilities and their social networks during the COVID-19 pandemicLianne Bakkum, Lotte Piekema, Linda Douma, et al.
Nederlands Tijdschrift Voor Geneeskunde|August 5, 2021
[Complications of contaminated drugs: how to reduce the number of future victims?]Philip G Frankenmolen, Caroline L Hoogerheide-Wiegerinck, Floor F van Bakkum, et al.
Gynecologic Oncology|November 9, 2007
Müllerian inhibiting substance type II receptor (MISIIR): a novel, tissue-specific target expressed by gynecologic cancersJamie N Bakkum-Gamez, Giovanni Aletti, Kriste A Lewis, et al.
Gynecologic Oncology|June 5, 2017
Cost-effectiveness of opportunistic salpingectomy for ovarian cancer preventionSarah E Dilley, Laura J Havrilesky, Jamie Bakkum-Gamez, et al.
Gynecologic Oncology|November 10, 2021
The cost of diagnosing endometrial cancer: Quantifying the healthcare cost of an abnormal uterine bleeding workupSimrit K Warring, Bijan Borah, James Moriarty, et al.
American Journal of Obstetrics and Gynecology|September 25, 2001
The severity of immune fetal hydrops is predictive of fetal outcome after intrauterine treatmentI L van Kamp, F J Klumper, R S Bakkum, et al.
Gynecologic Oncology|January 18, 2014
Oncolytic vaccinia virotherapy for endometrial cancerYu-Ping Liu, Jiahu Wang, Victoria A Avanzato, et al.
Gynecologic Oncology|November 20, 2013
Oncolytic measles and vesicular stomatitis virotherapy for endometrial cancerYu-Ping Liu, Michael B Steele, Lukkana Suksanpaisan, et al.
Gynecologic Oncology|December 4, 2018
Mesenchymal molecular subtype is an independent predictor of severe postoperative complications after primary debulking surgery for advanced ovarian cancerDiogo Torres, Amanika Kumar, Jamie N Bakkum-Gamez, et al.
Pageof 35